RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 66 filers reported holding RA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,048,000 | +109.6% | 21,823 | +104.5% | 0.00% | – |
| Q4 2019 | $500,000 | +228.9% | 10,670 | +65.5% | 0.00% | – |
| Q3 2019 | $152,000 | -14.1% | 6,447 | +9.7% | 0.00% | – |
| Q2 2019 | $177,000 | +110.7% | 5,878 | +57.8% | 0.00% | – |
| Q1 2019 | $84,000 | +50.0% | 3,725 | +21.6% | 0.00% | – |
| Q4 2018 | $56,000 | +60.0% | 3,063 | +57.7% | 0.00% | – |
| Q3 2018 | $35,000 | +84.2% | 1,942 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | +18.8% | 1,942 | -34.3% | 0.00% | – |
| Q1 2018 | $16,000 | -42.9% | 2,957 | -9.2% | 0.00% | – |
| Q4 2017 | $28,000 | -41.7% | 3,258 | 0.0% | 0.00% | – |
| Q3 2017 | $48,000 | -23.8% | 3,258 | 0.0% | 0.00% | – |
| Q2 2017 | $63,000 | +133.3% | 3,258 | +161.7% | 0.00% | – |
| Q1 2017 | $27,000 | +42.1% | 1,245 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | – | 1,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|